{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:56:23Z","timestamp":1791262583131,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.celrep.2025.116757","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:44:44Z","timestamp":1766151884000},"page":"116757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["An IL-12 partial agonist sustains intratumoral lymphocyte activation and detoxifies systemic IL-12 therapy"],"prefix":"10.1016","volume":"45","author":[{"given":"Ievgen","family":"Koliesnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Totagrande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhargavi","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Quyen","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Balasubrahmanyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Emmerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Rokkam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Buffone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Mehta-Damani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"de Waal Malefyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Greb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navneet","family":"Ratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Zuniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kastelein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul-Joseph","family":"Aspuria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Vivona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Oft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8662-074X","authenticated-orcid":false,"given":"Patrick J.","family":"Lupardus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2025.116757_bib1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ni.2366","article-title":"IL-12 family cytokines: immunological playmakers","volume":"13","author":"Vignali","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib2","doi-asserted-by":"crossref","first-page":"14002","DOI":"10.1073\/pnas.93.24.14002","article-title":"A functional interleukin 12 receptor complex is composed of two \u03b2-type cytokine receptor subunits","volume":"93","author":"Presky","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.celrep.2025.116757_bib3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4049\/jimmunol.153.1.128","article-title":"Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130","volume":"153","author":"Chua","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib4","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.cell.2021.01.018","article-title":"Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells","volume":"184","author":"Glassman","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116757_bib5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1084\/jem.181.1.399","article-title":"Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12","volume":"181","author":"Bacon","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2025.116757_bib6","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1073\/pnas.92.16.7307","article-title":"Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes","volume":"92","author":"Bacon","year":"1995","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.celrep.2025.116757_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/abbi.1999.1302","article-title":"Direct Interaction of STAT4 with the IL-12 Receptor","volume":"368","author":"Yao","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.celrep.2025.116757_bib8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1084\/jem.185.5.825","article-title":"Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 Cells","volume":"185","author":"Rogge","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2025.116757_bib9","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/intimm\/13.11.1433","article-title":"Signals delivered through TCR instruct IL-12 receptor (IL-12R) expression: IL-12 and tumor necrosis factor-\u03b1 synergize for IL-12R expression at low antigen dose","volume":"13","author":"Ahlers","year":"2001","journal-title":"Int. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/ni794","article-title":"T-bet is a STAT1-induced regulator of IL-12R expression in na\u00efve CD4+ T cells","volume":"3","author":"Afkarian","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib11","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1084\/jem.185.5.817","article-title":"Regulation of the Interleukin (IL)-12R \u03b22 Subunit Expression in Developing T Helper 1 (Th1) and Th2 Cells","volume":"185","author":"Szabo","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2025.116757_bib12","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood.V95.10.3183","article-title":"Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4","volume":"95","author":"Wang","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2025.116757_bib13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ni.2030","article-title":"Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages","volume":"12","author":"Liao","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib15","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.4049\/jimmunol.160.8.3642","article-title":"IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes","volume":"160","author":"Barbulescu","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib16","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.4049\/jimmunol.162.10.5894","article-title":"IL-18 and CD28 Use Distinct Molecular Mechanisms to Enhance NK Cell Production of IL-12-Induced IFN-\u03b3","volume":"162","author":"Walker","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4049\/jimmunol.148.1.92","article-title":"Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF\/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2","volume":"148","author":"Chan","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1084\/jem.173.4.869","article-title":"Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers","volume":"173","author":"Chan","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2025.116757_bib19","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1182\/blood.V87.9.3877.bloodjournal8793877","article-title":"Inhibition of Angiogenesis by Interleukin-12 Is Mediated by the Interferon-Inducible Protein 10","volume":"87","author":"Sgadari","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2025.116757_bib20","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.4049\/jimmunol.0903210","article-title":"IL-12 Suppresses Vascular Endothelial Growth Factor Receptor 3 Expression on Tumor Vessels by Two Distinct IFN-\u03b3\u2013Dependent Mechanisms","volume":"184","author":"Sorensen","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib21","article-title":"Interleukin-12 inhibits pathological neovascularization in mouse model of oxygen-induced retinopathy","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2025.116757_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.952231","article-title":"IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines","volume":"13","author":"Jia","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib23","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3\u2013related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2025.116757_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/cdd.2014.134","article-title":"New insights into IL-12-mediated tumor suppression","volume":"22","author":"Tugues","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.celrep.2025.116757_bib25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.medj.2023.03.007","article-title":"An optimized IL-12-Fc expands its therapeutic window, achieving strong activity against mouse tumors at tolerable drug doses","volume":"4","author":"Gutierrez","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.celrep.2025.116757_bib26","first-page":"76","article-title":"Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses","volume":"9","author":"Portielje","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.116757_bib27","first-page":"3983","article-title":"Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer. Clin. cancer Res, Off. J. Am. Assoc","volume":"5","author":"Portielje","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2025.116757_bib28","first-page":"409","article-title":"Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies","volume":"3","author":"Atkins","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.116757_bib29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1479-5876-5-66","article-title":"Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma","volume":"5","author":"Lenzi","year":"2007","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.celrep.2025.116757_bib30","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1038\/s41467-024-49034-1","article-title":"Anti-PD-1 cis-delivery of low-affinity IL-12 activates intratumoral CD8+T cells for systemic antitumor responses","volume":"15","author":"Zou","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116757_bib31","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.4049\/jimmunol.162.8.4943","article-title":"A Fatal Cytokine-Induced Systemic Inflammatory Response Reveals a Critical Role for NK Cells","volume":"162","author":"Carson","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib32","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1182\/blood.V96.4.1465","article-title":"Coadministration of interleukin-18 and interleukin-12 induces a fatal inflammatory response in mice: critical role of natural killer cell interferon-\u03b3 production and STAT-mediated signal transduction","volume":"96","author":"Carson","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2025.116757_bib33","first-page":"2541","article-title":"Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production","volume":"90","author":"Leonard","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2025.116757_bib34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3390\/cells9020400","article-title":"Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy","volume":"9","author":"Nguyen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.celrep.2025.116757_bib35","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.4049\/jimmunol.153.4.1697","article-title":"Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production","volume":"153","author":"Nastala","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib36","first-page":"2661","article-title":"A dose-escalation and pharmacokinetic study of subcutaneously administered recombinant human interleukin 12 and its biological effects in Japanese patients with advanced malignancies","volume":"6","author":"Ohno","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.116757_bib37","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1158\/2326-6066.CIR-22-0705","article-title":"mWTX-330, an IL 12 INDUKINE Molecule, Activates and Reshapes Tumor-infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity","volume":"11","author":"Nirschl","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.celrep.2025.116757_bib38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1158\/1535-7163.MCT-23-0336","article-title":"XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies","volume":"23","author":"Patel","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.celrep.2025.116757_bib39","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1200\/JCO.2007.15.6794","article-title":"Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma","volume":"26","author":"Daud","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.celrep.2025.116757_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi8075","article-title":"Cell surface\u2013tethered IL-12 repolarizes the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapy","volume":"8","author":"Jones","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2025.116757_bib41","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/s41590-024-01925-7","article-title":"Local delivery of cell surface-targeted immunocytokines programs systemic antitumor immunity","volume":"25","author":"Santollani","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1362775","article-title":"A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in healthy volunteers","volume":"15","author":"Kenney","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib43","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1438800","article-title":"Heterodimeric Fc-fused IL12 shows potent antitumor activity by generating memory CD8+ T cells","volume":"7","author":"Jung","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.celrep.2025.116757_bib44","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.4049\/jimmunol.164.6.3330","article-title":"IFN-\u03b3-Dependent and -Independent Mechanisms in Adverse Effects Caused by Concomitant Administration of IL-18 and IL-12","volume":"164","author":"Nakamura","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib45","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.4049\/jimmunol.148.10.3125","article-title":"IL-12 receptor. II. Distribution and regulation of receptor expression","volume":"148","author":"Desai","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib46","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.str.2024.07.010","article-title":"Structure and assembly of the human IL-12 signaling complex","volume":"32","author":"Chen","year":"2024","journal-title":"Structure"},{"key":"10.1016\/j.celrep.2025.116757_bib47","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2025.116757_bib48","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1172\/JCI0215950","article-title":"IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells","volume":"110","author":"Parihar","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2025.116757_bib49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/019262339902700112","article-title":"The Toxicology of Interleukin-12: A Review","volume":"27","author":"Car","year":"1999","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.celrep.2025.116757_bib50","first-page":"1693","article-title":"Role of interferon-gamma in interleukin 12-induced pathology in mice","volume":"147","author":"Car","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.celrep.2025.116757_bib51","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.4049\/jimmunol.149.6.1957","article-title":"Genomic structure and strain-specific expression of the natural killer cell receptor NKR-P1","volume":"149","author":"Giorda","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib52","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0952-7915(02)00329-1","article-title":"Development and selection of NKT cells","volume":"14","author":"MacDonald","year":"2002","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12975-021-00923-3","article-title":"Natural Killer Cells Are Present in Rag1\u2212\/\u2212 Mice and Promote Tissue Damage During the Acute Phase of Ischemic Stroke","volume":"13","author":"Rolfes","year":"2022","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.celrep.2025.116757_bib54","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12864-019-6344-3","article-title":"Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors","volume":"21","author":"Zhong","year":"2020","journal-title":"BMC Genom."},{"key":"10.1016\/j.celrep.2025.116757_bib55","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41467-024-44789-z","article-title":"Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity","volume":"15","author":"Dean","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116757_bib56","article-title":"Tissue-specific transcriptional profiles and heterogeneity of natural killer cells and group 1 innate lymphoid cells","volume":"3","author":"Lopes","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2025.116757_bib57","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1038\/s41467-021-23324-4","article-title":"Interpretation of T cell states from single-cell transcriptomics data using reference atlases","volume":"12","author":"Andreatta","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116757_bib58","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116757_bib59","first-page":"1183","article-title":"Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma. Clin. cancer Res, Off. J. Am. Assoc","volume":"4","author":"Motzer","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2025.116757_bib60","series-title":"Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology","first-page":"43","article-title":"Clinical Trials with IL-12 in Cancer Immunotherapy","author":"Lasek","year":"2016"},{"key":"10.1016\/j.celrep.2025.116757_bib61","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.annonc.2019.12.008","article-title":"Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients","volume":"31","author":"Algazi","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.celrep.2025.116757_bib62","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1158\/1078-0432.CCR-10-2490","article-title":"A Phase 1 Study of AS1409, a Novel Antibody-Cytokine Fusion Protein, in Patients with Malignant Melanoma or Renal Cell Carcinoma","volume":"17","author":"Rudman","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.116757_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1158\/1078-0432.CCR-18-1512","article-title":"First-In-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors","volume":"25","author":"Strauss","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.116757_bib64","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-cancerbio-061421-040258","article-title":"Strategies for Heating Up Cold Tumors to Boost Immunotherapies","volume":"7","author":"Zabransky","year":"2023","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.celrep.2025.116757_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101134","article-title":"The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis","volume":"41","author":"Li","year":"2021","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.celrep.2025.116757_bib66","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/protein\/gzw040","article-title":"Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions","volume":"29","author":"Schlothauer","year":"2016","journal-title":"Protein Eng., Des. Sel."},{"key":"10.1016\/j.celrep.2025.116757_bib67","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nbt0798-677","article-title":"An efficient route to human bispecific IgG","volume":"16","author":"Merchant","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2025.116757_bib68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nbt.1601","article-title":"Enhanced antibody half-life improves in vivo activity","volume":"28","author":"Zalevsky","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2025.116757_bib69","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.molimm.2015.02.017","article-title":"Crystal structures of immunoglobulin Fc heterodimers reveal the molecular basis for heterodimer formation","volume":"65","author":"Choi","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib70","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2025.116757_bib71","article-title":"SeuratExtend: Streamlining Single-Cell RNA-Seq Analysis Through an Integrated and Intuitive Framework","volume":"2024","author":"Hua","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2025.116757_bib72","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41587-020-0472-9","article-title":"Multiplex digital spatial profiling of proteins and RNA in fixed tissue","volume":"38","author":"Merritt","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2025.116757_bib73","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.celrep.2019.01.041","article-title":"RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell Types","volume":"26","author":"Monaco","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2025.116757_bib74","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/s41590-024-01883-0","article-title":"High-dimensional single-cell analysis of human natural killer cell heterogeneity","volume":"25","author":"Rebuffet","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.116757_bib75","doi-asserted-by":"crossref","unstructured":"Kolde, R. (2010). pheatmap: Pretty Heatmaps. In CRAN: Contributed Packages. The R Foundatio. https:\/\/doi.org\/10.32614\/cran.package.pheatmap.","DOI":"10.32614\/CRAN.package.pheatmap"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725015293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725015293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:47:38Z","timestamp":1791262058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124725015293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2211124725015293"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116757","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An IL-12 partial agonist sustains intratumoral lymphocyte activation and detoxifies systemic IL-12 therapy","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116757"}}